Wednesday, 5 May 2021
Opening Session

Welcome to the HepHIV 2021 Lisbon & Virtual Conference
Ricardo Baptista Leite, Local conference co-chair, MP Portugal, UNITE

Conference objectives and overview
Dorthe Raben, EuroTEST Initiative, CHIP, University of Copenhagen

Welcome message from the Portuguese Minister of Health
António Lacerda Sales, Assistant State Secretary for Health, Portugal

Welcome from the European Commission: The EU response on HIV, viral hepatitis, STIs and TB in the future
John Ryan, Director of Public Health, DG Sante, European Commission

Post-2020/COVID-19 and progress towards the SDG targets: Where are we?
Andrea Ammon, Director, European Centre for Disease Prevention and Control (ECDC)

‘The changed landscape’ – providing testing for HIV/STIs/hepatitis/TB in the era of COVID-19
Hans Kluge, Regional Director, WHO Regional Office for Europe. Represented by Nicole Seguy, WHO Regional Office for Europe in the live discussion

Country Spotlight: Portugal’s progress in reaching the global targets and interventions for integration of testing
Rui Portugal, Deputy Director-General of Health, National Directorate of the Portuguese Ministry

Community perspective on enabling environments for integrated testing and linkage to care across Europe
Daniel Simões, Coalition Plus/GAT, Portugal

Live discussion - Part one

Live discussion - Part two

Thursday, 6 May 2021
PLENARY SESSION 1: SPECIAL SESSION: Impact of COVID-19 on prevention and testing services for HIV, viral hepatitis, STIs and TB: Building back better

Keynote address:
Perspectives from the US National Institute of Allergy and Infectious Diseases of the National Institutes of Health
H.Clifford Lane, Deputy Director for Clinical Research and Special Projects, National Institute of Allergy and Infectious Diseases (NIAID), USA

PS1/02 Impact of the COVID-19 pandemic on testing and linkage to care for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region
Ann Sullivan

PS1/03 s.a.m. Health: Germany’s first digital sexual health service is providing COVID-safe remote STI testing and counselling during the Covid-19 Pandemic and beyond
Carlo Kantwerk

PS1/04 Rapid HIV testing and linkage in rehabilitation centers during COVID-19 pandemics, Yekaterinburg and Sverdlovsk region, Russia
Viktor Stanilevskiy

PS1/05 European testing week: adaptation of testing services during the COVID-19 pandemic
Ben Collins

Live Discussion

ABSTRACT DRIVEN SESSION 1: The use of new technologies to increase testing coverage

AS1/01 RiskRadar: the 1st integrated ICT tool on combination prevention for hepatitis/HIV/TB/STI
Lello Cosmaro

AS1/02 An evaluation of the outcomes of an online HIV self-sampling service to inform risk communication and future online testing policy
Jennifer Taylor

AS1/03 Efficacy of an on-screen computer reminder for HIV screening in primary care based on indicator conditions: a cluster randomized controlled trial
Cristina Agustí

AS1/04 Breaking the Chain? A once in a generation opportunity to find and treat HIV during UK’s COVID-19 lockdown Anamika Basu

Live discussion

PLENARY SESSION 2: Combination prevention in HIV, viral hepatitis, STIs and TB

PS2/01 “Prevention is hard, Combination is key” – Good example of HIV/STI combination prevention in Scotland
Claudia Estcourt, Glasgow Caledonian University, Scotland, United Kingdom

PS2/02 Combination disease prevention in prisons: a comprehensive programme in Luxembourg
Patrick Hoffmann, Luxembourg Directorate of Health

PS2/03 TB an HBV/HCV/HIV-combined preventive activities in the Netherlands
Gerard de Vries, RIVM, Netherlands

PS2/04 The ‘Get Tested LeEDs’ project: clinical impact and cost-effectiveness of opt-out emergency department testing for bloodborne viruses (BBVs) in England
Elisabeth Smout

Live Discussion

EU Health Project Symposium: lessons learned from the INTEGRATE Joint Action

Video presentation of the processes behind the main outcomes of the INTEGRATE JA

Short intro to the Online training module on prevention, testing and linkage to care

Panel discussion: Integration of Infectious Diseases –keeping the momentum
Panelists:
Valerie Delpech, Public Health England, UK
Lella Cosmaro, Lila Milano, Italy
Jordi Casabona, El Centre d'Estudis Epidemiològics sobre les Infeccionsde Transmissió Sexual i Sida de Catalunya (CEEISCAT), Catalonia, Spain
Ann Sullivan, SSAT Chelsea Westminister Hospital, UK
Nadia Gasbarrini,Villa Maraini, Italy
Jack Lambert, University of Dublin & Mater Misericordiae University Hospital, Ireland
Walter Cullen, University of Dublin, Ireland
Jeff Lazarus, Barcelona Institute for Global Health (IS Global), Catalonia, Spain
Teymur Noori, European Centre for Disease Prevention and Control (ECDC)
Thomas Seyler, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Ana Gutierrez Burgos, European Commission, DGSANTE

Friday, 7 May 2021

PLENARY SESSION 3: Implementing integrated testing strategies

PS3/01 Experience in innovative approach to testing for HIV, hepatitis and STIs
Raimonda Matulionytė, Vilnius University Hospital Santaros Klinikos, Lithuania

PS3/02 Integrated screening for TB, HIV and HCV at the primary healthcare level
Maka Danelia, National Center for Disease Control and Public Health, Georgia

PS3/04 Evolution of key indicators for community-based voluntary counseling and testing activity in Europe: COBATEST Network 2017-2019
Megi Gogishvili

PS3/05 Implementing self-test programmes during COVID-19
Robert Hejzak, Czech AIDS Help Society

Live Discussion

ABSTRACT DRIVEN SESSION 2: Models of testing and linkage to care for PWID and PWUD

AS2/01 Testing and linkage to care services for 1000 people who inject drugs from Bucharest through the implementation of a three level HCV elimination strategy
Raluca Teodorescu

AS2/02 Integrated harm reduction responses to HIV and viral hepatitis in the COVID-19 pandemic: a global overview
Sam Shirley-Beavan

AS2/03 Feasibility of HCV micro-elimination: HCV test and treatment in two harm reduction services in Milan, Italy
Sara Mazzilli

AS2/04 Blood-borne virus testing in people who inject drugs with a history of sex work
Eva Emanuel

AS2/05 HCV care for PWID in Europe - results from a civil society-led monitoring
Rafaela Rigoni

Live Discussion

PLENARY SESSION 4: SPECIAL SESSION: People who inject/use drugs (EMCDDA/ECDC)

PS4/01 Keeping the HIV/Hepatitis targets for PWID on track during the Covid-19 pandemic: European perspectives
Thomas Seyler, EMCDDA

PS4/02 New evidence on testing and linkage to care for PWIDs
Otilia Mardh, European Centre for Disease Prevention and Control (ECDC)

PS4/03 Ensuring delivering of testing and linked services for PWID/PWUD during the COVID19 pandemic
Marios Atzemis, Positive Voice, Greece

PS4/04 What is needed to promote prisons as a setting for case-finding and treatment of infections among PWIDs?
Fadi Meroueh, Montpellier University Hospital, France

Live Discussion

CLOSING SESSION: Integrating disease areas and settings

Short report from Conference Days 1 and 2 and Best Poster Award
Jürgen Rockstroh, HepHIV2021 Conference Co-chair, HIV Outpatient Clinic, University of Bonn, Germany 

Panel Discussion: Integrated testing and linkage to care for HIV, viral hepatitis, TB, STIs and other infectious diseases: Paving the way forward amidst a global pandemic
Panellists:
Cary James, World Hepatitis Alliance
Andrew Winter, IUSTI Europe
Jens Lundgren, CHIP, University of Copenhagen
Nicole Seguy, WHO Regional Office for Europe
Yazdan Yazdanpanah, ANRS Maladies Infectieuses Emergentes, France
Nikoloz Chkhartishvili, Infectious Diseases, AIDS & Clinical Immunology Research Center (IDACIRC),Georgia
Paul Sommerfeld, TB Europe Coalition
Nikos Dedes, European AIDS Treatment Group (EATG)
Ricardo Baptista Leite, MP Portugal, UNITE

Conference Call to Action and closing remarks
Daniel Simões, HepHIV2021 Conference Co-chair, Coalition Plus/GAT, Portuga

Posters

The HepHIV2021 Lisbon & Virtual Conference Best Poster Award was won by:
PO1/01 Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region
L. Fernàndez-López^1,2 , D. Simões^3,4, M. Krone⁵ , J. Casabona^1,2

Poster Session 1 (PO1): Innovative testing services during the COVID-19 pandemic: lessons learned

PO1/01 Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region
L. Fernàndez-López , D. Simões, M. Krone , J. Casabona

PO1/02 Screening, diagnosis and treatment of HCV/HIV during the COVID 19 pandemic: lessons from a Mobile Outreach Program in Lisbon, Portugal
F. Barata , C. Pereira , I. Pereira , H. Faria , R. Sousa Coutinho , D. Gil Morais

PO1/03 Impact of COVID-19 on a Portuguese ONG screening site: implications for practice
A.L. Rosa  P. Morais, E. Sávio,  J. Conceição, C. Rodrigues

PO1/04 Strengthening community responses on prevention and care for PLHIV and key populations during the COVID19 emergency crisis
M. Reiriz Rojas , A. Bertó Moran , D. García Morcillo

PO1/05 Going cashless in a cash-constrained crisis: Implementation of a COVID-19 emergency response program for optimising engagement in HIV care among Thai men who have sex with men and transgender women
T. Anand , C. Nitpolprasert

PO1/06 Use of mobile applications and social networks for HIV testing among MSM and PrEP obtaining at COVID-19 conditions, in Ukraine
A. Chernyshev , A. Bogoslavets , R. Marchenko 

Poster Session 2 (PO2): Impact of COVID-19 on provision of services for people who inject/use drugs

PO2/01 Changes to the provision of services for people who inject drugs in England, Wales and Northern Ireland during the COVID-19 pandemic
S. Croxford , E. Emanuel , A. Ibitoye, J. Njoroge, C. Edmundson, L. Slater, E. Phipps

PO2/02 COVID-19 impact on harm reduction programs (testing and counselling) in low threshold drug services in Germany
A. Krings, G. Steffen, C. Germershausen, R. Zimmermann

PO2/03 The impact of the COVID-19 pandemic on harm reduction services in a prison and addiction centres in the Balearic Islands, Spain: preliminary results from a novel hepatitis C elimination programme
A. Herranz, À. Vilella, A. Agius, J.M. Alonso, A. Rodríguez, C.A Picchio, D. Guy, C. Pujol, M. Buti, J. Lazarus

PO2/04 Using peer support to facilitate hepatitis C treatment during the COVID-19 pandemic
J.S. Lambert, B. West, T. McHugh, J. Farrell, C. Moran, l. Vidal

Poster Session 3 (PO3): New testing technologies to increase testing coverage: HIV self-testing and home-based sampling

PO3/01 Key learnings from an HIV at-home testing campaign for Dutch MSM and trans people during the COVID-19 pandemic
K. Vermey, P. Zantkuijl, H. Bos, M. Lasschuyt, K. Visser, W. Zuilhof

PO3/02 Self HIV testing in Poland implementation during COVID-19
M. Ankiersztejn-Bartczak , A. Stola

PO3/03 Preliminary results of a pilot project on HIV self-testing among men who have sex with men in the City of Zagreb, Croatia, 2020/2021
N. Bogdanić, D. Dubravić, J. Kresović, M. Erceg, A. Dišković, T. Beganović, Š. Zekan, J. Begovac

PO3/04 Get an HIV test at home! Increasing access to testing, in the pandemic context, by implementing a pilot program of home-based HIV testing in Romania
M. Lixandru, S. Ciobanu, C.-L. Hanu, A. Schiau

PO3/05 TESTATE C Plus: an online self-sampling intervention for hepatitis C in gay, bisexual and other men who have sex with men and trans women in Catalonia (Spain)
C. Agustí , H. Martínez, E. Martró, S. Moreno, E. Muntada, P. Romano, L. Egea, R. Mora, L. Villegas, J. Mena, Q. Roqueta, J. Hernández, M. Vázquez, A. Not, A. Pérez, J. Colom, J. Casabona

PO3/06 High acceptability and effectiveness of an online self-sampling intervention for HIV in gay, bisexual and other men who have sex with men and trans women in Spain (TESTATE VIH)
C. Agustí Benito, H. Martínez, V. González, S. Moreno,  E. Muntada, P. Romano, L. Egea, R. Muñoz, J. Hoyos, J. Casabona

Poster Session 4 (PO4): Integrated testing programmes for hepatitis/HIV/TB/STI: health care settings

PO4/01 Socio-demographic inequalities in HIV testing patterns among MSM in Spain
C. Folch, A. Díaz, M.C. Vázquez, S. Meyer, J. Casabona

PO4/02 Towards a hepatitis C-free hospital: results after one year of hepatitis C virus screening in a tertiary hospital emergency department in a high-income country
J. Llaneras Artigues, A. BarreiraDíaz, A. Rando Segura, J. Bañares Sanchez, B. Meza Ramos, L. Ruíz Ortega, J.R. Marques Soares, A. Monforte Pallares, O. Orozco Gálvez, M. Riveiro-Barciela, F. Velasquez Orozco, F. RodríguezFrías, M. Arranz Betegon, R. Esteban Mur, M. Buti Ferret

PO4/03 Implementation of HIV rapid testing model in government medical facilities in Leningrad Region, Russia in 2020
S. Semikova, P. Supronenko, V. Stanilevskiy, M. Petrova, O. Prokof’eva , V. Surkova, A. Merzlyakova, Y. Godunova, A. Kovelenov, A. Chuykov, N. Mironova, A. Zakowicz

PO4/04 Quality of life in people living with HIV in Romania and Spain
J. Lazarus, M. Kall, U. Fresán, D. Guy, G. Brown, C. Burgui, J. Castilla, V. Ionel Grecu, F. Dumitrescu, V. Delpech

PO4/05 HCV screening of immigrants at arrival: an opportunity to linkage to care of a population with limited access to Health Care system
M. Riveiro-Barciela, B. Treviño, N. Serre, A. Rando, F. Salvador, A. Barreira-Díaz, A. Palom, E. Vargas, D. Pou, L. Roade, I. Molina, F. Rodríguez-Frías, M. Buti

PO4/06 Expanding integrated HCV/HIV testing to alcohol dependent clients attending treatment centres for drug and alcohol dependency in Lithuania
L. Stoniene, E Subata, A Sirvinskiene, A Grice, M.L. Jakobsen, S. Finne Jakobsen, D. Raben, C. Rae, A. Sullivan

PO4/07 Distributing a questionnaire for women attending a Sexual Health Clinic increases PrEP uptake
S. Strachan, S. Jaffer, V. Apea, D. Campbell, J. Domino, L. Davies, J. Dugdale, K. Nambier, D. Onyago, J. Ott, M. Ross, J. Stevenson, N. Turner, G. Singh, A. Sullivan

PO4/08 HIV and viral hepatitis transmission knowledge among female health care providers and females in the general population in Constanta Region, Romania
A.-M. Schweitzer, M. Bogdan, F.S. Stoian, I. Ciocea

Poster Session 5 (PO5): Integrated testing programmes for hepatitis/HIV/TB/STI: community-based settings

PO5/01 Community-based voluntary counseling and testing for HIV, sífilis and HCV in Europe: COBATEST Network 2019
M. Gogishvili, L. Fernàndez López, J. Casabona Barbara

PO5/02 Rapid Hiv test in Sardinia, a lookback at first 5 years of Lila Cagliari testing service
G. DessI, F. Cardinale, V. Mascia

PO5/03 Reaching 95-95-95: 3 years of the Portuguese League Against AIDS performing screening tests and promoting therapeutical compliance
M.E. Saraiva, S. Melo Refoios, M. Ferrão, G. Bento, R. Castro, R. Vicente, L. Nunes

PO5/04 Promoting autonomy and self-care of people living with HIV and/or hepatitis through a community-based approach: the example of the Takari project in French Guiana
A.-S. Petit, J.-P. Dada, L. Napuchi, C. Mathurin, M. Shahisavandi, M. Préau, D. Michels, M. Gaillet, C. Michaud, C. Piedrafita y Costa

PO5/05 Contributions of (+) Screening = (+) Life Project in the access of the Trans and Sex Worker population to early detection and screening of STIs
P. Costa, F. Aguiar, S. Correia, A. Silva, P. Belmonte, F. Neves

Poster Session 6 (PO6): Models of testing and linkage to care for people who inject/use drugs

PO6/01 Point-of-care screening combined with nursing and peer-based outreach work to enhance testing and treatment for hepatitis C among people who use drugs, people who experience homelessness, and migrants: the REACH U Study
C. Merendeiro, R. Lopes, I. Marinho, R. Marinho, J. Grebely, A. Nave

PO6/02 Efficiency of HIV rapid testing and social services for IDU women in Tomsk, Russia
E. Borzunova, A. Chernov, V. Stanilevskiy, N. Mironova, A. Chuykov, A.M. Żakowicz

PO6/03 Hepatitis C cascade of care (CoC) for people who use drugs (PWUD) under opiate substitution treatment (OST) in Greece
O. Anagnostou, K. Micha, K. Kaliva, E. Tsirogianni, E. Petroulaki, I. Detsi, M. Kollitsida, G. Androulakis, M. Gargoulaki, V. Karagounis, A. Katsili, S. Kollia, A. Kotsalis, M. Spirellis, K. Stamatopoulos, V. Stavridou, C. Tanis, P. Tsekoura, Y. Topalidou Stepin, A. Tsantilas, M. Chalkiadakis, A. Drimousi, N. Papadopoulos, A. Theocharis

PO6/04 Decentralized HCV consultation: an HCV micro-elimination project in the community
Á. Ávila, T. Azevedo, M.J. Braz, S. Busi, F. Calinas, R. Costa, T. Mamede, C. Marques, R. Pires, J. Santa Maria

PO6/05 Portugal’s first mobile drug consumption room: client characteristics and linkage to care
H. Taylor, A. Curado, Â. Leite, J. Pires, V. Correia, P. Nunes, J. Caldas, M. Alves, J. Canêdo, D. Gautier

PO6/06 Could the 2010 HIV outbreak in Athens, Greece be prevented? A mathematical modelling study
I. Gountas, G. Nikolopoulos, G. Touloumi, A. Fotiou, K. Souliots

PO6/07 Eliminating hepatitis C on the Balearic Islands by linking patients who use drugs from addiction service centers, a local NGO, a prison and a mobile methadone bus to HCV care
J.V Lazarus, À. Vilella, C.A Picchio, A. Herranz, M. Buti

PO6/08 Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs (PWUD)
J. Valencia, P. Ryan, J. Lazarus, J. Troya, G. Cuevas, I. Cañamares, I. Escobar

PO6/09 Designing a strategy to reengage PWID lost to follow-up in HIV care, the case of the PISCIS Cohort in Spain
J. Palacio-Vieira, J.M. Reyes Urueña, A. Imaz, A. Bruguera, L. Force, A.-J. Orti-Llaveria, J.-M Llibre, I. Vilaró, F. Homar Borràs, V. Falcó, M. Riera, P. Domingo, E. de Lazzari, I. Chivite, E. Letang, J.-M Miró, J. Casabona

PO6/10 Impact of opiate substitution treatment (OST) on hepatitis and HIV high risk behaviors
M. Vasileiou, O. Anagnostou, I. Elefsiniotis